diabetes - 2/27

Entry	Author	Date	Location
GI Dynamics Starts Trading on Aussie Exchange, Eyes U.S. Pilot Study for Device in Diabetes and Obesity	Arlene Weintraub	09/14/11	Boston
Valeritas Raises $150M for Insulin Device	Arlene Weintraub	09/13/11	New York
Pfizer Grows in Cambridge, Repligen Eyes Imaging Approval, GI Dynamics Gets Aussie IPO, & More Boston-Area Life Sciences News	Erin Kutz	09/02/11	Boston
GI Dynamics Raises $85M USD in Aussie IPO	Erin Kutz	08/30/11	Boston
Genomatica Files for IPO, Tandem Diabetes Raises $12M, Zogenix Looks to Raise Almost $50M, & More San Diego Life Sciences News	Bruce V. Bigelow	08/25/11	San Diego
San Diego’s Tandem Diabetes Raises $12 Million While Insulin Pump Is Under Review	Bruce V. Bigelow	08/22/11	San Diego
T2 Nabs $23M, Ironwood Seeks IBS Drug Approval, FDA Sets Deadline for Alkermes Drug, & More Boston-Area Life Sciences News	Erin Kutz	08/12/11	Boston
Bydureon FDA Deadline Set	Luke Timmerman	08/10/11	San Diego
Helmsley Trust Funds New Boston-Based Website for Diabetes Patients	Arlene Weintraub	08/10/11	Boston
Amylin & Takeda Halt Obesity Drug Development	Bruce V. Bigelow	08/04/11	San Diego
GI Dynamics and Exa File for IPOs in Weight Loss Devices, Automotive Software	Gregory T. Huang	08/04/11	Boston
Biogen Gets Euro Approval, BSX Shows Solid Q2, Alkermes Tries Again, & More Boston-Area Life Sciences News	Erin Kutz	07/29/11	Boston
Bydureon Sent Back to FDA	Luke Timmerman	07/28/11	San Diego
Trius and Bayer Sign Deal, Brooks Buys Nexus Biosystems, Wildcat Discovery Gets $7.5M Financing, & More San Diego Life Sciences News	Bruce V. Bigelow	07/28/11	San Diego
Amylin, Alkermes Once-Weekly Diabetes Drug Passes Heart Trial Demanded by FDA	Luke Timmerman	07/07/11	San Diego
Optivia Biotech Finds its Way to Profits, With a Little Help from Friends at the FDA	Luke Timmerman	07/05/11	San Francisco
Amylin Buoyed by Diabetes Trials, Vital Therapies Raises $22.6M, Acutus Medical Gets Seed Cash, & More San Diego Life Sciences News	Bruce V. Bigelow	06/30/11	San Diego
Bristol Churns Out Diabetes Data	Arlene Weintraub	06/27/11	New York
The Auto Magnate and the Scientist: How Mass General is Working With Lee Iacocca to Find a Diabetes Cure	Arlene Weintraub	06/24/11	Boston
A San Diego Sampler from the War on Diabetes	Bruce V. Bigelow	06/24/11	San Diego
Link Between Cardiovascular And Metabolic Diseases? That’s What Esperion Therapeutics Founder Has Been Trying To Tell You	Thomas Lee	06/23/11	Detroit
Amylin, Alkermes Diabetes Med OKd in EU	Luke Timmerman	06/21/11	San Diego
Orexigen Halts U.S. Work on Weight Loss Drug, Illumina Cuts Price for Sequencing Patient Genomes, Ambit Pulls IPO, & More San Diego Life Sciences News	Bruce V. Bigelow	06/09/11	San Diego
Amylin Gets TRO Against Lilly	Bruce V. Bigelow	05/26/11	San Diego
Shire Buys Advanced BioHealing for $750 Million	Arlene Weintraub	05/17/11	New York
Amylin Sues Eli Lilly, Arguing Breach of Contract in Marketing Rival Diabetes Drug	Luke Timmerman	05/16/11	San Diego
Halozyme Deal Could Yield $83M, Wireless Health Leaders Converge, Readers Vote on Worst Drug Names, & More San Diego Life Sciences News	Bruce V. Bigelow	05/12/11	San Diego
Kilimanjaro Energy Seeks to Pop Loose Trillions’ Worth of Underground Oil, Save the World	Luke Timmerman	05/02/11	San Francisco
CoDa Therapeutics Adds $19M Round, Led by Domain, to Pursue Diabetes Complication	Luke Timmerman	04/18/11	San Diego
Biotech’s Missed Opportunity: Small-Town and Rural America	Luke Timmerman	04/18/11	National
Page 2 of 9	« previous page · next page »

Entry

Author

Date

Location

GI Dynamics Starts Trading on Aussie Exchange, Eyes U.S. Pilot Study for Device in Diabetes and Obesity

Arlene Weintraub

09/14/11

Boston

Valeritas Raises $150M for Insulin Device

Arlene Weintraub

09/13/11

New York